[go: up one dir, main page]

Mellado et al., 1984 - Google Patents

Preparation and biological activity of taxol acetates

Mellado et al., 1984

Document ID
4103718496461008538
Author
Mellado W
Magri N
Kingston D
Garcia-Arenas R
Orr G
Horwitz S
Publication year
Publication venue
Biochemical and Biophysical Research Communications

External Links

Snippet

Synthesis and biological activity of 2′-acetyltaxol and 7-acetyltaxol are reported. Activity is measured in vivo by cytotoxicity toward the macrophage-like cell line J774. 2, and in vitro by promotion of microtubule assembly in the absence of exogenous GTP. Addition of an acetyl …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48369—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atom
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms

Similar Documents

Publication Publication Date Title
Mellado et al. Preparation and biological activity of taxol acetates
KR100281606B1 (en) Polymer-linked paclitaxel derivatives, methods for their preparation and pharmaceutical compositions comprising the same
Parness et al. Structure-activity study of cytotoxicity and microtubule assembly in vitro by taxol and related taxanes
Rodrigues et al. Synthesis and β-lactamase-mediated activation of a cephalosporin-taxol prodrug
US20020198141A1 (en) Molecular conjugates for use in treatment of cancer
JPH0665675B2 (en) Novel bryostatin 4-8
JP3430322B2 (en) Spongistatin 5, 7, 8 and 9
Ottolina et al. Synthesis of ester derivatives of chloramphenicol by lipase-catalyzed transesterification in organic solvents
US20040127561A1 (en) Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings, method therefor
EP4434546A1 (en) Novel acid-sensitive aptamer triptolide conjugate and application
JPH0267218A (en) Virus genome inactivator
EP1105379B1 (en) Water soluble analogs and prodrugs of paclitaxel
Shimoda et al. Chemo-enzymatic synthesis of ester-linked taxol–oligosaccharide conjugates as potential prodrugs
SK10562002A3 (en) Semi-synthetic taxanes with antitumor and antiangiogenetic activities
US6380161B1 (en) Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions
US6172205B1 (en) Synthetic process toward total synthesis of eleutherobin and its analogues and uses thereof
CN113713117A (en) Albumin-binding tumor environment-responsive antitumor prodrug and preparation method and application thereof
WO1996011683A1 (en) New cytotoxic agents
イドリッシュアリモハマド Water-Solubilization by Using Symmetrically Branched Oligoglycerol Trimers
IE902703A1 (en) Anthracycline derivatives
JP2007039346A (en) Taxoid derivative bound to tumor-specific antibody and method for producing the same
JPS59175492A (en) Mitomycin c derivative and its preparation
EP1572191A1 (en) Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings